An open‐label phase 2 trial of entospletinib in indolent non‐Hodgkin lymphoma and mantle cell lymphoma
Andorsky, David J., Kolibaba, Kathryn S., Assouline, Sarit, Forero‐Torres, Andres, Jones, Vicky, Klein, Leonard M., Patel‐Donnelly, Dipti, Smith, Mitchell, Ye, Wei, Shi, Wen, Yasenchak, Christopher A., Sharman, Jeff P.
Published in British journal of haematology (01.01.2019)
Published in British journal of haematology (01.01.2019)
Get full text
Journal Article
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL
Friedberg, Jonathan W., Forero-Torres, Andres, Bordoni, Rodolfo E., Cline, Vivian J.M., Patel Donnelly, Dipti, Flynn, Patrick J., Olsen, Gregg, Chen, Robert, Fong, Abraham, Wang, Yinghui, Yasenchak, Christopher A.
Published in Blood (28.12.2017)
Published in Blood (28.12.2017)
Get full text
Journal Article
Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma
Berenson, James R., Yellin, Ori, Bessudo, Alberto, Boccia, Ralph V., Noga, Stephen J., Gravenor, Donald S., Patel‐Donnelly, Dipti, Siegel, Robert S., Kewalramani, Tarun, Gorak, Edward J., Nassir, Youram, Swift, Regina A., Mayo, Debra
Published in British journal of haematology (01.02.2013)
Published in British journal of haematology (01.02.2013)
Get full text
Journal Article
Multicenter Randomized Phase II Study of Weekly or Twice-Weekly Bortezomib Plus Rituximab in Patients With Relapsed or Refractory Follicular or Marginal-Zone B-Cell Lymphoma
DE VOS, Sven, GOY, André, GLENN, Martha, GREGORY, Stephanie A, HOLLADAY, Charles, ZHANG, Tracy, BORAL, Anthony L, DAKHIL, Shaker R, SALEH, Mansoor N, MCLAUGHLIN, Peter, BELT, Robert, FLOWERS, Christopher R, KNAPP, Mark, HART, Lowell, PATEL-DONNELLY, Dipti
Published in Journal of clinical oncology (20.10.2009)
Published in Journal of clinical oncology (20.10.2009)
Get full text
Journal Article
Brentuximab Vedotin in Frontline Therapy of Hodgkin Lymphoma in Patients with Significant Comorbidities Ineligible for Standard Chemotherapy (SGN35-015 Part E)
Yasenchak, Christopher, Bordoni, Rodolfo, Patel-Donnelly, Dipti, Larson, Timothy, Goldschmidt, Jerome, Boccia, Ralph, Cline, Vivian J. M., Jain, Shweta, Liu, Jingmin, Beck, Joseph Thaddeus
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Brentuximab Vedotin in Frontline Therapy of Hodgkin Lymphoma in Patients with Significant Comorbidities Ineligible for Standard Chemotherapy (SGN35-015 Part E)
Yasenchak, Christopher A., Bordoni, Rodolfo, Patel-Donnelly, Dipti, Larson, Timothy, Goldschmidt, Jerome, Boccia, Ralph V., Cline, Vivian J.M., Mamidipalli, Adrija, Liu, Jingmin, Beck, Joseph T.
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
Brentuximab vedotin with dacarbazine or nivolumab as frontline cHL therapy for older patients ineligible for chemotherapy
Friedberg, Jonathan W., Bordoni, Rodolfo, Patel-Donnelly, Dipti, Larson, Timothy, Goldschmidt, Jerome, Boccia, Ralph, Cline, Vivian J. M., Mamidipalli, Adrija, Liu, Jingmin, Akyol, Alev, Yasenchak, Christopher A.
Published in Blood (29.02.2024)
Published in Blood (29.02.2024)
Get full text
Journal Article
Frontline brentuximab vedotin in Hodgkin lymphoma and CD30-expressing peripheral T-cell lymphoma for older patients and those with comorbidities
Yasenchak, Christopher A., Bordoni, Rodolfo Eduardo, Yazbeck, Victor Y., Patel-Donnelly, Dipti, Larson, Tim, Sims, Robert Brownell, Mei, Matthew Genyeh
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Brentuximab Vedotin in Front-Line Therapy of Hodgkin Lymphoma (HL) and CD30-Expressing Peripheral T-Cell Lymphoma (PTCL) in Adults Age 60 and Above
Yasenchak, Christopher A., Bordoni, Rodolfo, Yazbeck, Victor, Patel-Donnelly, Dipti, Larson, Timothy, Newhook, Trevor, Ho, Linda, Mei, Matthew
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2 study
Awan, Farrukh T., Thirman, Michael J., Patel-Donnelly, Dipti, Assouline, Sarit, Rao, Arati V., Ye, Wei, Hill, Brian, Sharman, Jeff P.
Published in Leukemia & lymphoma (03.07.2019)
Published in Leukemia & lymphoma (03.07.2019)
Get full text
Journal Article
Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline
de Haas, Valérie, Ismaila, Nofisat, Advani, Anjali, Arber, Daniel A, Dabney, Raetasha S, Patel-Donelly, Dipti, Kitlas, Elizabeth, Pieters, Rob, Pui, Ching-Hon, Sweet, Kendra, Zhang, Ling
Published in Journal of clinical oncology (20.01.2019)
Published in Journal of clinical oncology (20.01.2019)
Get full text
Journal Article
Phase 2 Study of Frontline Brentuximab Vedotin Plus Nivolumab in Patients with Hodgkin Lymphoma Aged ≥60 Years
Yasenchak, Christopher A., Bordoni, Rodolfo, Yazbeck, Victor, Patel-Donnelly, Dipti, Anderson, Thomas, Larson, Timothy, Newhook, Trevor, Mei, Matthew, Ho, Linda, Friedberg, Jonathan W.
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma
Burke, John M., Shustov, Andrei, Essell, James, Patel-Donnelly, Dipti, Yang, Jay, Chen, Robert, Ye, Wei, Shi, Wen, Assouline, Sarit, Sharman, Jeff
Published in Clinical lymphoma, myeloma and leukemia (01.08.2018)
Published in Clinical lymphoma, myeloma and leukemia (01.08.2018)
Get full text
Journal Article
Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma Patients
Yasenchak, Christopher A., Bordoni, Rodolfo, Patel-Donnelly, Dipti, Larson, Timothy, Goldschmidt, Jerome, Boccia, Ralph V., Cline, Vivian J.M., Sacchi, Mariana, Forero-Torres, Andres, Sims, Robert B., Liu, Jingmin, Friedberg, Jonathan W.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Frontline brentuximab vedotin as monotherapy or in combination for older Hodgkin lymphoma patients
Yasenchak, Christopher A., Bordoni, Rodolfo Eduardo, Patel-Donnelly, Dipti, Larson, Tim, Goldschmidt, Jerome H., Boccia, Ralph V., Cline, Vivian Jean M., Forero-Torres, Andres, Sims, Robert Brownell, Newhook, Trevor, Friedberg, Jonathan W.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Results of a completed phase I study of LAM-002 (apilimod dimesylate), a first-in-class phosphatidylinositol-3-phosphate 5 kinase (PIKfyve) inhibitor, administered as monotherapy or with rituximab or atezolizumab to patients with previously treated follicular lymphoma or other B-cell cancers
Magid Diefenbach, Catherine S., Cohen, Jonathan B, Harb, Wael A., Ansell, Stephen M., Nastoupil, Loretta J., Abramson, Jeremy S., Lakhani, Nehal J., Schreeder, Marshall T., Sher, Taimur, Patel-Donnelly, Dipti, Aboulafia, David Michael, Fuchs, Candace A., Nix, Darrell, Landrette, Sean, Graham, Patricia S, King, Lydia B, Young, Peter L., Miller, Langdon L., Lichenstein, Henri, Rutherford, Sarah C.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Westin, Jason, Maris, Michael B, Jacobson, Caron A, Patel, Prapti, Lakhani, Nehal, Harb, Wael, Patel-Donnelly, Dipti, McCaul, Kelly, Escobar, Carolina, Klencke, Barbara, Al-Katib, Ayad M.
Published in Clinical lymphoma, myeloma and leukemia (01.01.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.01.2022)
Get full text
Journal Article
Long-term follow-up of brentuximab vedotin ± dacarbazine as first line therapy in elderly patients with Hodgkin lymphoma
Friedberg, Jonathan W., Forero-Torres, Andres, Holkova, Beata, Goldschmidt, Jerome H., Boccia, Ralph V., Bordoni, Rodolfo, Cline, Vivian Jean M., Patel-Donnelly, Dipti, Flynn, Patrick J., Olsen, Gregg A., Chen, Robert W., Galderisi, Faith, Wang, Yinghui, Sharman, Jeff Porter, Yasenchak, Christopher A.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Brentuximab Vedotin in Combination with Dacarbazine or Bendamustine for Frontline Treatment of Hodgkin Lymphoma in Patients Aged 60 Years and Above: Interim Results of a Multi-Cohort Phase 2 Study
Yasenchak, Christopher A., Forero-Torres, Andres, Cline-Burkhardt, Vivian Jean Mikao, Bordoni, Rodolfo E, Patel-Donnelly, Dipti, Flynn, Patrick J., Chen, Robert, Fong, Abraham, Friedberg, Jonathan W.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article